Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04121351
Other study ID # ICREC ref:19IC5429
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date October 1, 2019
Est. completion date April 23, 2021

Study information

Verified date April 2021
Source Imperial College London
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study will assess the physiological demands related to Singing for Lung Health participation.


Description:

This study will assess the physiological demands experienced by healthy volunteers participating in components of a Singing for Lung Health session. Oxygen consumption, heart rate, and fixed body sensor output puts related to balance and movement intensity will be assessed. The same parameters will also be assessed during walking on a treadmill at different speeds for comparison.


Recruitment information / eligibility

Status Terminated
Enrollment 8
Est. completion date April 23, 2021
Est. primary completion date April 23, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - Healthy adult - Able to undertake singing components - Able to undertake walking test - No contraindications to exercise - No contraindications to spirometry as per American Thoracic Society/European Respiratory Society criteria - Capacity to consent to exercise testing. Exclusion Criteria: - Any health condition that would preclude them from singing or impede physical activity - Inability to comply or follow singing exercise instructions - Active musculoskeletal disease impairing exercise.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Singing participation
Participants will follow a 15 minute protocol consisting of the components of a Singing for Lung Health class, and a short period walking on a treadmill.

Locations

Country Name City State
United Kingdom National Heart and Lung Institute, Imperial College London London

Sponsors (1)

Lead Sponsor Collaborator
Imperial College London

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Oxygen consumption in mL per kilogram per minute during different components of Singing for Lung Health(physical warm up, rhythm exercises, pitch exercises, vocal exercises, repertoire and relaxation) Assessed using portable metabolic measurement equipment (Oxycon Mobile made by Vyaire). Single assessment at baseline.
Secondary Heart rate during different components of Singing for Lung Health (physical warm up, rhythm exercises, pitch exercises, vocal exercises, repertoire and relaxation). Assessed using a portable heart rate monitor. Single assessment at baseline.
Secondary Comparison of oxygen consumption, in mL per kilogram per minute, achieved during each component of Singing for Lung Health with walking at different speeds Oxygen consumption, in mL per kilogram per minute, will be assessed during different components of Singing for Lung Health(physical warm up, rhythm exercises, pitch exercises, vocal exercises, repertoire and relaxation. This will be compared with oxygen consumption while walking at three speeds on a treadmill (slow, medium and brisk). Oxygen consumption will be assessed using portable metabolic measurement equipment (Oxycon Mobile made by Vyaire). Single assessment at baseline.
Secondary Movement intensity during different components of Singing for Lung Health(physical warm up, rhythm exercises, pitch exercises, vocal exercises, repertoire and relaxation). Assessed with the McRoberts fixed-body sensor MoveTest device. Single assessment at baseline.
Secondary Changes in centre of mass during different components of Singing for Lung Health (physical warm up, rhythm exercises, pitch exercises, vocal exercises, repertoire and relaxation). Assessed with the McRoberts fixed-body sensor MoveTest device. Single assessment at baseline
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1